IT1217445B - Composizione farmaceutiche orosolubili contenti acetilcisteina - Google Patents

Composizione farmaceutiche orosolubili contenti acetilcisteina

Info

Publication number
IT1217445B
IT1217445B IT20386/88A IT2038688A IT1217445B IT 1217445 B IT1217445 B IT 1217445B IT 20386/88 A IT20386/88 A IT 20386/88A IT 2038688 A IT2038688 A IT 2038688A IT 1217445 B IT1217445 B IT 1217445B
Authority
IT
Italy
Prior art keywords
acetylcistein
pharmaceutical composition
composition containing
soluble pharmaceutical
soluble
Prior art date
Application number
IT20386/88A
Other languages
English (en)
Other versions
IT8820386A0 (it
Inventor
Antonio Zigiotti
Paolo Lualdi
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon Sa filed Critical Altergon Sa
Priority to IT20386/88A priority Critical patent/IT1217445B/it
Publication of IT8820386A0 publication Critical patent/IT8820386A0/it
Priority to EP89107231A priority patent/EP0339508B1/en
Priority to DE8989107231T priority patent/DE68903988T2/de
Priority to AT89107231T priority patent/ATE83651T1/de
Priority to ES89107231T priority patent/ES2052802T3/es
Priority to US07/343,350 priority patent/US4970236A/en
Application granted granted Critical
Publication of IT1217445B publication Critical patent/IT1217445B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT20386/88A 1988-04-29 1988-04-29 Composizione farmaceutiche orosolubili contenti acetilcisteina IT1217445B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT20386/88A IT1217445B (it) 1988-04-29 1988-04-29 Composizione farmaceutiche orosolubili contenti acetilcisteina
EP89107231A EP0339508B1 (en) 1988-04-29 1989-04-21 Mouth-soluble pharmaceutical compositions containing acetylcysteine
DE8989107231T DE68903988T2 (de) 1988-04-29 1989-04-21 Acetylcystein enthaltende mundloesliche arzneimittel.
AT89107231T ATE83651T1 (de) 1988-04-29 1989-04-21 Acetylcystein enthaltende mundloesliche arzneimittel.
ES89107231T ES2052802T3 (es) 1988-04-29 1989-04-21 Composiciones farmaceuticas solubles en la boca que contienen acetilcisteina.
US07/343,350 US4970236A (en) 1988-04-29 1989-04-26 Mouth-soluble pharmaceutical compositions containing acetyl-cysteine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20386/88A IT1217445B (it) 1988-04-29 1988-04-29 Composizione farmaceutiche orosolubili contenti acetilcisteina

Publications (2)

Publication Number Publication Date
IT8820386A0 IT8820386A0 (it) 1988-04-29
IT1217445B true IT1217445B (it) 1990-03-22

Family

ID=11166252

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20386/88A IT1217445B (it) 1988-04-29 1988-04-29 Composizione farmaceutiche orosolubili contenti acetilcisteina

Country Status (6)

Country Link
US (1) US4970236A (it)
EP (1) EP0339508B1 (it)
AT (1) ATE83651T1 (it)
DE (1) DE68903988T2 (it)
ES (1) ES2052802T3 (it)
IT (1) IT1217445B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231012B (it) * 1989-07-27 1991-11-08 Zambon Spa Composizione farmaceutica per uso orale contenente nac.
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
DK0481294T4 (da) * 1990-10-19 2001-06-18 Spirig Ag Fast, hurtigt-opløseligt lægemiddelpræparat indeholdende N-acetylcystein
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
WO1995017900A1 (en) * 1993-12-30 1995-07-06 Arcturus Pharmaceutical Corporation Methods for the treatment of the central nervous system or eye involving pathogenic oxidation pathways
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
ES2114817B1 (es) * 1996-05-16 1999-02-16 Zambon S A Asociacion farmacologica entre n-acetilcisteina y levulosa para la prevencion de la muerte celular y enfermedades asociadas.
US5962421A (en) * 1996-05-16 1999-10-05 Zambon, S.A. Pharmacological association between N-acetylcysteine and levulose for preventing cellular death and related diseases
US5719196A (en) * 1996-07-24 1998-02-17 Leiras Oy Method of treating respiratory infections or complications derived therefrom in humans which includes oral administration of xylitol
DE69612097D1 (de) * 1996-10-29 2001-04-19 Staroil Ltd Mundlösliche Zusammensetzungen die N-Acetylcystein und Cyclodextrin enthalten
AU3072397A (en) * 1996-11-20 1998-06-10 Sang Whang Enterprises, Inc. Potassium and sodium bicarbonate for increased blood buffers
WO2000007575A2 (en) * 1998-07-31 2000-02-17 Mount Sinai Hospital Methods and compositions for increasing insulin sensitivity
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
TR200900881A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
IT1399492B1 (it) * 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
US10139321B2 (en) * 2016-07-29 2018-11-27 Alpha-Tec Systems, Inc. Mucolytic tablet for a sample collection device
WO2019051182A1 (en) 2017-09-07 2019-03-14 The Children's Hospital Of Philadelphia COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYSTATIN C-HISTORY AMYLOID ANGIOPATHY (HCCAA) AND OTHER NEURODEGENERATIVE DISORDERS ASSOCIATED WITH ABERRANT AMYLOID DEPOTS

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE304574C (it) *
US2888380A (en) * 1954-11-05 1959-05-26 Merck & Co Inc S-ethyl cysteine compositions for combatting tubercle bacilli
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
FR1451177A (fr) * 1962-03-06 1966-01-07 Degussa Procédé de préparation d'une n-acylhomocystéine thiolactone
US3591686A (en) * 1967-08-01 1971-07-06 Mead Johnson & Co Anti-inflammatory compositions and methods utilizing n-acylcysteines and the beta-alkyl and carboxyl derivatives thereof
US3629452A (en) * 1968-02-19 1971-12-21 Oreal Method of reducing excessive secretions of sebum by oral administration of amino acid derivatives
USRE29256E (en) * 1969-10-07 1977-06-07 Recherche Pharmaceutiques Et Scientifiques Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith
CA1080024A (en) * 1975-12-24 1980-06-24 Leonard Spooner Confection containing xylitol
JPS535112A (en) * 1976-03-08 1978-01-18 Santen Pharmaceutical Co Ltd New cysteine derivatives
IT1194474B (it) * 1983-11-23 1988-09-22 Magis Farmaceutici Derivati della cisteina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
DE3343141A1 (de) * 1983-11-29 1985-06-05 Hermann P.T. 7400 Tübingen Ammon Verwendung von cystein-derivaten oder deren salzen, zur steigerung der insulinsekretion der langerhans'schen inseln der bauchspeicheldruese
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
JPH0610132B2 (ja) * 1985-11-27 1994-02-09 千寿製薬株式会社 糖尿病性白内障治療薬
CH666814A5 (it) * 1986-07-24 1988-08-31 Inpharzam Int Sa Composizione farmaceutica idrosolubile contenente n-acetil-cisteina.
CH667590A5 (it) * 1986-07-24 1988-10-31 Inpharzam Int Sa Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .

Also Published As

Publication number Publication date
EP0339508A1 (en) 1989-11-02
US4970236A (en) 1990-11-13
IT8820386A0 (it) 1988-04-29
EP0339508B1 (en) 1992-12-23
DE68903988T2 (de) 1993-06-17
DE68903988D1 (de) 1993-02-04
ES2052802T3 (es) 1994-07-16
ATE83651T1 (de) 1993-01-15

Similar Documents

Publication Publication Date Title
IT1217445B (it) Composizione farmaceutiche orosolubili contenti acetilcisteina
PT82841A (en) Process for the preparation of novel amino acid derivatives and of pharmaceutical compositions containing the same
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
IL95691A0 (en) Thienylcarboxylates of amino alcohols,their preparation and pharmaceutical compositions containing them
IL90435A (en) 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them
PT841903E (pt) Composicao farmaceutica oral contendo agentes activos antimicrobianos e pantoprazole com libertacao diferida
IL89167A0 (en) Substituted pyrroles,their manufacture and pharmaceutical compositions containing them
NZ231508A (en) Hydroxamic acid derivatives, pharmaceutical compositions and intermediate compounds
ES2103587T3 (es) Composiciones terapeuticas ingeribles, estables y absorbibles de nadh y de nadph.
IL95503A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
SE8902288D0 (sv) Farmaceutisk komposition
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
IL84041A (en) Retinoids,their manufacture and pharmaceutical compositions containing them
DE59811768D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
JPS646262A (en) Morpholine derivative, manufacture and medicinal composition
DK0437388T3 (da) Præparater indeholdende aktive bestanddele, som er beskyttet mod nedbrydning i drøvtyggeres vom
IL88927A0 (en) Thienoazepines,their production and pharmaceutical compositions containing them
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
PH27446A (en) Compound with gastric acid inhibitory effect
HRP20000781B1 (hr) Šumeći pripravci
ATE65395T1 (de) Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel.
GB2021409A (en) Pharmaceutical composition
DE3479728D1 (en) Derivatives of thiophenesulfonamide, their preparation and pharmaceutical composition for the topical treatment of elevated intraocular pressure
DE3485601D1 (it)